Reports for TAKEDA CANADA INC
Company Name
TAKEDA CANADA INC
Totals |
||
Shortage reports |
52 |
|
| Actual shortage: | 1 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 0 (0%) | |
| Resolved: | 51 (98%) | |
Discontinuation Reports |
7 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 7 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
0 (0%) |
|
Overdue reports |
0 (0%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FOSRENOL | 250MG | TABLET (CHEWABLE) | Resolved | 2020-05-25 | 2021-02-12 | 115725 |
| ADYNOVATE | 250UNIT | POWDER FOR SOLUTION KIT | Resolved | 2022-06-30 | 2022-09-22 | 163980 |
| ADDERALL XR | 25MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-04-21 | 2022-05-05 | 159220 |
| ELAPRASE | 2MG | SOLUTION | Resolved | 2019-04-29 | 2019-05-02 | 82729 |
| RIXUBIS | 3000UNIT | POWDER FOR SOLUTION KIT | Resolved | 2023-07-13 | 2023-08-28 | 198634 |
| ADYNOVATE | 3000UNIT | KIT POWDER FOR SOLUTION | Resolved | 2020-11-13 | 2021-01-06 | 128401 |
| TAKHZYRO | 300MG | SOLUTION | Resolved | 2021-12-15 | 2022-01-13 | 151175 |
| VYVANSE | 30MG | CAPSULE | Resolved | 2021-12-02 | 2021-12-12 | 150417 |
| VYVANSE | 30MG | CAPSULE | Resolved | 2022-12-19 | 2023-01-16 | 178913 |
| DEXILANT | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-08-05 | 2021-09-15 | 143737 |
| DEXILANT | 30MG | CAPSULE (DELAYED RELEASE) | Actual shortage | 2024-03-22 | 2024-03-23 | 223152 |
| FEIBA NF | 3250UNIT | POWDER FOR SOLUTION KIT | Resolved | 2020-08-11 | 2020-10-13 | 122033 |
| FEIBA NF | 3250UNIT | KIT POWDER FOR SOLUTION | Resolved | 2021-06-04 | 2021-06-30 | 140469 |
| TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-31 | 2018-09-21 | 57003 |
| TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2019-02-21 | 2019-06-11 | 76478 |
| TECTA | 40MG | TABLET (ENTERIC-COATED) | Resolved | 2020-11-16 | 2021-01-22 | 128447 |
| VYVANSE | 40MG | CAPSULE | Resolved | 2021-09-22 | 2021-10-07 | 146031 |
| VYVANSE | 40MG | CAPSULE | Resolved | 2021-12-02 | 2021-12-12 | 150414 |
| VYVANSE | 40MG | TABLET (CHEWABLE) | Resolved | 2023-02-24 | 2023-03-07 | 185609 |
| ONDISSOLVE ODF | 4MG | FILM, SOLUBLE | Resolved | 2017-04-05 | 2017-05-11 | 5605 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AGRYLIN | 0.5MG | CAPSULE | Discontinued | 2023-11-15 | 2024-03-01 | 210182 |
| ACTOS | 15MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44428 |
| FOSRENOL | 250MG | TABLET (CHEWABLE) | Discontinued | 2022-12-20 | 2023-04-30 | 178916 |
| ACTOS | 30MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44433 |
| PANTO IV | 40MG | POWDER FOR SOLUTION | Discontinued | 2017-03-15 | 2017-03-15 | 2969 |
| ACTOS | 45MG | TABLET | Discontinued | 2018-04-02 | 2018-04-02 | 44438 |
| ULORIC | 80MG | TABLET | Discontinued | 2021-08-17 | 2022-01-04 | 144266 |
Showing 1 to 7 of 7